AngioDynamics, Inc. ANGO
12.03 USD +0.29 (+2.51%)
Nov 9, 2026, 9:30 AM EST
11.91 Day range 12.03
9.39 52-week range 16.29
- YTD
- -6.35%
- 1 year
- +2.51%
News
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares…
benzinga.com AngioDynamics Reports DIRECT Study Findings Showing Longer Overall Survival In Stage III Pancreatic Ductal Adenocarcinoma, Gets Category I CPT Code For Open IRE Ablation Of Pancreatic Tumors, Effective January 1, 2027 Prospective, multicenter FDA IDE study found an IRE-based treatment strategy was associated with longer overall survival in Stage III pancreatic cancer; new Category I CPT code for open pancreatic…
benzinga.com HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18 HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $19 to $18.
benzinga.com AngioDynamics Stock Is Falling Thursday: What's Going On? ANGO stock drops 21% as AngioDynamics reports Q1 results, names Eric Honroth as new CEO, and reaffirms FY27 guidance.
benzinga.com Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo beat estimates but cut FY26 outlook; oil jumped 5%.
benzinga.com AngioDynamics Q1 2027 Earnings Call: Complete Transcript AngioDynamics (NASDAQ:ANGO) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to…
benzinga.com Earnings Scheduled For October 8, 2026 Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss at $0.15 per share on revenue of $266.42 million. • Helen Of Troy (NASDAQ:HELE) is projected to…
benzinga.com AngioDynamics Appoints Eric Honroth As President And CEO, Effective November 2 Mr. Honroth will succeed Jim Clemmer, who will depart the Board on November 2, 2026, and will remain in a consulting capacity to ensure a smooth transition.The appointment follows a Board-led search…
benzinga.com AngioDynamics Affirms FY2027 Adj EPS Guidance of $(0.29)-$(0.24) vs $(0.27) Est; Affirms FY2027 Sales Guidance of $336.000M-$341.000M vs $337.400M Est AngioDynamics (NASDAQ:ANGO) affirms FY2027 Adj EPS guidance from $(0.29)-$(0.24) to $(0.29)-$(0.24) vs $(0.27) analyst estimate. Affirms FY2027 sales outlook from $336.000 million-$341.000 million to…
benzinga.com AngioDynamics Q1 Adj. EPS $(0.04) Beats $(0.11) Estimate, Sales $80.915M Beat $80.500M Estimate AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.11) by 63.64 percent. This is a 60 percent increase over losses of $(0.10)…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million. Omeros (NASDAQ:OMER) stock…
- benzinga.com HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19 HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from $16 to $19.
- benzinga.com Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20 Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from $16 to $20.
- benzinga.com Full Transcript: AngioDynamics Q4 2026 Earnings Call AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For…
- benzinga.com Earnings Scheduled For July 14, 2026 Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarterly earnings at $3.25 per share on revenue of $862.92 million. • JPMorgan Chase (NYSE:JPM) is…
- benzinga.com AngioDynamics Sees FY2027 Adj EPS $(0.29)-$(0.24) vs $(0.16) Est; Sees Sales $336.000M-$341.000M vs $329.600M Est AngioDynamics (NASDAQ:ANGO) is looking for FY2027 Adj EPS of $(0.29)-$(0.24) vs $(0.16) analyst estimate. sees sales of $336.000 million-$341.000 million vs $329.600 million analyst estimate.
benzinga.com AngioDynamics Q4 Adj. EPS $(0.07) Beats $(0.09) Estimate, Sales $86.607M Beat $80.400M Estimate AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 133.33 percent decrease over losses of…- benzinga.com AngioDynamics Says FDA Approves IDE Application To Initiate RELIEF Study Evaluating NanoKnife IRE Platform As Minimally Invasive Treatment Option For Men With Benign Prostatic Hyperplasia AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality…
benzinga.com Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock jumped 11.73%.- benzinga.com AngioDynamics Announces 2-Yr Results From PRESERVE Pivotal Trial Demonstrating Durable Oncologic Control And Sustained Safety Profile For NanoKnife System In Focal Ablation Of Intermediate-Risk Prostate Cancer Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented at AUA 2026AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring…
benzinga.com Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16 Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $18 to $16.- benzinga.com Earnings Scheduled For April 2, 2026
- benzinga.com AngioDynamics Raises FY2026 Adj EPS Guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) vs $(0.29) Est; Raises FY2026 Sales Guidance from $312.000M-$314.000M to $313.500M-$315.500M vs $312.881M Est AngioDynamics (NASDAQ:ANGO) raises FY2026 Adj EPS guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) vs $(0.29) analyst estimate. Raises FY2026 sales outlook from $312.000 million-$314.000 million to…
- benzinga.com AngioDynamics Q3 Adj. EPS $(0.07) Beats $(0.11) Estimate, Sales $78.423M Beat $76.767M Estimate AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 36.36 percent. This is a 12.5 percent increase over losses of…
benzinga.com Nasdaq Gains Over 1% On War De-Escalation Hopes: Investor Fear Eases, But Fear & Greed Index Remains In 'Extreme Fear' Zone Stocks end higher, Fear & Greed Index eases, Trump suggests quick military withdrawal from Iran, earnings disappoint for RH and Nike.
benzinga.com Acuity, Lindsay And 3 Stocks To Watch Heading Into Thursday U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Corp expected to post earnings, Globalstar shares jump after Amazon acquisition talks, AngioDynamics…- benzinga.com AngioDynamics Expands European Indications For NanoKnife System To Include Soft Tissue Ablation For Tumors Of Liver, Pancreas, Kidney, And Prostate Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Option for Major Solid Tumor TypesAngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative…
benzinga.com Dow Jumps Over 400 Points; US Services Activity Falls In December 
benzinga.com US Stocks Mixed; Nasdaq Gains Over 50 Points - benzinga.com Earnings Scheduled For January 6, 2026
- benzinga.com AngioDynamics Affirms FY2026 Adj EPS Guidance of $(0.33)-$(0.23) vs $(0.33) Est; Raises FY2026 Sales Guidance from $308M-$313M to $312M-$314M vs $310.204M Est Fiscal Year 2026 Financial GuidanceFor fiscal year 2026 the company now expects:Guidance Metric Guidance Action Current Guidance(as of January 6, 2026) Previous Guidance(as of October 2, 2025)Net
benzinga.com AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday U.S. stock futures up, focus on AngioDynamics, Microchip Tech, AAR earnings. Galapagos to wind down cell therapy.
benzinga.com Dow Hits Record High After US Strike On Venezuela: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral Zone U.S. stocks rise on Venezuela raids, Dow hits record high. CNN Money Fear and Greed Index improves but remains in Neutral zone at 46.8.
benzinga.com What to Expect from AngioDynamics's Earnings 
benzinga.com Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results 
benzinga.com Stock Market Today: Dow Futures Slip, S&P 500 Rises Amid Mixed Trade—Berkshire, Occidental, Fermi In Focus U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed.
benzinga.com S&P 500 Closes At Record High: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with record S&P 500 level.
benzinga.com AngioDynamics, Globant And 3 Stocks To Watch Heading Into Thursday US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics.- benzinga.com Earnings Scheduled For July 15, 2025
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Gold Moves Higher; US Private Sector Job Growth Tops Estimates 
benzinga.com Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - benzinga.com Earnings Scheduled For April 2, 2025
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Crude Oil Down 1%; US Weekly Jobless Claims Decline 
benzinga.com Earnings Scheduled For January 8, 2025 - benzinga.com Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday - benzinga.com Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday